Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by roadking08on Sep 24, 2019 9:13pm
118 Views
Post# 30161273

RE:RE:RE:I agree, it's very very terrible

RE:RE:RE:I agree, it's very very terribleJD, you can think  it’s a guilt trip has much as you want. No one this afternoon wanted to put a dime over .24. Until further notice, share holder losses are much more a fact than an opinion and accumulating.wow your personal guidance is something not to bring to the bank, I hope you have a disclaimer.
can you please, and when I say please I mean it big time. What are your past and present winners so that we can continue to follow the all mighty JD. (Im giving you a window of 5 years) just in case.
Your looking like more and more (past post) looking like someone who wants to preach on drinking the koolaid as sour as it might be on eventually lower price if that could ever be possible. I’ve personally made a pant load betting against your insights.
please tell me my great mentor of this great stock, what items have you bought to this stock lately and I’ll even allow you to go in distant past. You idiot, you make me think of Draghi in Europe going negative and bragging about it.
Please give us a prelude of your thoughts once we go under .20.
I’m personally betting against you, only because its been a very very bankable thing to do so far and will continue to be a good and will continue to realm the profits.
just a suggestion to al, shareholders but starting tomorrow I think it’s much much better to follow price action than JD. Let’s reverse the trend. 
Bullboard Posts